Cheetham, C <br/><br/>
Losartan, an angiotensin type I receptor antagonist, improves conduit vessel endothelial function in Type II diabetes.  [electronic resource] 

 -  Clinical science (London, England : 1979)  Jan 2001 
 - 13-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0143-5221 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin I--metabolism<br/>Angiotensin Receptor Antagonists<br/>Cross-Over Studies<br/>Diabetes Mellitus, Type 2--physiopathology<br/>Double-Blind Method<br/>Endothelium, Vascular--drug effects<br/>Female<br/>Humans<br/>Losartan--pharmacology<br/>Male<br/>Middle Aged<br/>Vasodilation--drug effects